Organon & Co.

NYSE:OGN   3:59:50 PM EDT
24.76
-0.87 (-3.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.30B
Current PE5.69
Forward PE 4.9
2yr Forward PE 4.56
See more stats
Estimates Current Quarter
Revenue$1.53 Billion
Adjusted EPS$1.18
See more estimates
10-Day MA$25.10
50-Day MA$28.73
200-Day MA$32.37
See more pivots

Organon & Co. Stock, NYSE:OGN

30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302
Phone: +1.551.430.6900
Number of Employees: 9300

Description

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within womenâ??s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.